Companies / Boston Scientific
Boston Scientific
BSX United States
ID 121 · CIK 885725 · reconciled 2026-10-10T16:41
SEC EDGAR filings ↗ Raw model extractions
Employees (legacy)
Revenue FY2025
20.1B
▲ 19.9% vs FY2024
Net profit FY2025
2.9B
▲ 56.7% vs FY2024
Total assets FY2025
43.7B
▲ 10.9% vs FY2024
Stockholders' equity FY2025
24.2B
▲ 11.3% vs FY2024
Operating cash flow FY2025
4.5B
▲ 32.0% vs FY2024
EPS (diluted) FY2025
1.94
▲ 55.2% vs FY2024
Employees FY2025
59,000
▲ 11.3% vs FY2024
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
All entities
Segment data comes from F4: entity names are clustered across models with Qwen, then each period is a majority vote.
Unlike F1–F3 there is no 2-model minimum — hover a value to see how many models reported it.
Vote results
| Source | Validated | Discarded | Calculated | Empty | Discard rate |
|---|---|---|---|---|---|
| F1 · income statement | 1,353 | 139 | 287 | 488 | 9.3% |
| F2 · balance sheet | 2,557 | 266 | 0 | 825 | 9.4% |
| F3 · cash flow | 493 | 61 | 625 | 239 | 11.0% |
| F5 · human capital | 58 | 2 | 0 | 396 | 3.3% |
Re-run plan for this company
| Action | Source | Form | Period end | Accession | Tier | Fields | Missing models |
|---|---|---|---|---|---|---|---|
| run missing model | F1 | 10-K405 | 1999-12-31 | 0000950135-00-001894 | 1 | shares_outstanding, eps_basic, eps_diluted, revenue, income_before_tax, net_profit, cost_of_revenue | Qwen3.6-27B-Q8_0, no-ai-xblr |
| run third ai | F1 | 10-Q | 1997-03-31 | 0000910647-97-000139 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1997-06-30 | 0000910647-97-000195 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1997-09-30 | 0000910647-97-000259 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1996-03-31 | 0000950135-96-002164 | 3 | eps_diluted[3mo], eps_diluted[ytd] | no-ai-xblr |
| run missing model | F2 | 10-K405 | 1999-12-31 | 0000950135-00-001894 | 1 | cash_and_equivalents, total_current_assets, total_assets, total_current_liabilities, long_term_debt, total_stockholders_equity | Qwen3.6-27B-Q8_0, no-ai-xblr |
| skip | F2 | 10-K | 2011-12-31 | 0000885725-12-000006 | total_liabilities | ||
| skip | F2 | 10-K | 2024-12-31 | 0000885725-25-000011 | total_liabilities | ||
| skip | F2 | 10-K | 2001-12-31 | 0000912057-02-011989 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-K | 2000-12-31 | 0000950135-01-001146 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-K | 2003-12-31 | 0000950135-04-001301 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-K | 1996-12-31 | 0000950135-97-001518 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-K | 1998-12-31 | 0000950135-99-001755 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2017-03-31 | 0000885725-17-000019 | total_liabilities | ||
| skip | F2 | 10-Q | 2026-06-30 | 0000885725-26-000053 | total_liabilities | ||
| skip | F2 | 10-Q | 1996-06-30 | 0000910647-96-000142 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 1996-09-30 | 0000910647-96-000194 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 1997-06-30 | 0000910647-97-000195 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2000-06-30 | 0001072613-00-000833 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2002-06-30 | 0001072613-02-001227 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2002-09-30 | 0001072613-02-001753 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2004-03-31 | 0001072613-04-000973 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2004-06-30 | 0001072613-04-001472 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2007-03-31 | 0001072613-07-001076 | total_liabilities | no-ai-xblr | |
| run missing model | F3 | 10-K405 | 1999-12-31 | 0000950135-00-001894 | 1 | net_cash_provided_by_operating_activities, net_cash_provided_by_financing_activities, net_cash_provided_by_investment_activities, capital_expenditure | Qwen3.6-27B-Q8_0, no-ai-xblr |
| run missing model | F5 | 10-K405 | 1999-12-31 | 0000950135-00-001894 | 2 | employees_total | Qwen3.6-27B-Q8_0, no-ai-xblr |